JP2024533975A5 - - Google Patents
Info
- Publication number
- JP2024533975A5 JP2024533975A5 JP2024506896A JP2024506896A JP2024533975A5 JP 2024533975 A5 JP2024533975 A5 JP 2024533975A5 JP 2024506896 A JP2024506896 A JP 2024506896A JP 2024506896 A JP2024506896 A JP 2024506896A JP 2024533975 A5 JP2024533975 A5 JP 2024533975A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- alkyl
- acceptable salt
- compound according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163231156P | 2021-08-09 | 2021-08-09 | |
| US63/231,156 | 2021-08-09 | ||
| PCT/US2022/039674 WO2023018636A1 (en) | 2021-08-09 | 2022-08-08 | Compounds that inhibit pi3k isoform alpha and methods for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533975A JP2024533975A (ja) | 2024-09-18 |
| JP2024533975A5 true JP2024533975A5 (https=) | 2025-07-28 |
Family
ID=83188497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506896A Pending JP2024533975A (ja) | 2021-08-09 | 2022-08-08 | Ｐｉ３ｋアイソフォームアルファを阻害する化合物及びがんを処置するための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20240343728A1 (https=) |
| EP (1) | EP4363414A1 (https=) |
| JP (1) | JP2024533975A (https=) |
| KR (1) | KR20240051953A (https=) |
| CN (1) | CN118159534A (https=) |
| AU (1) | AU2022325819A1 (https=) |
| CA (1) | CA3227902A1 (https=) |
| CL (1) | CL2024000327A1 (https=) |
| CO (1) | CO2024000448A2 (https=) |
| CR (1) | CR20240045A (https=) |
| DO (1) | DOP2024000019A (https=) |
| EC (1) | ECSP24008488A (https=) |
| GE (1) | GEAP202416449A (https=) |
| IL (1) | IL310588A (https=) |
| JO (1) | JOP20240020A1 (https=) |
| MA (1) | MA63885B1 (https=) |
| MX (1) | MX2024000708A (https=) |
| PE (1) | PE20240652A1 (https=) |
| WO (1) | WO2023018636A1 (https=) |
| ZA (1) | ZA202401094B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202541794A (zh) | 2022-11-02 | 2025-11-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之靶向別位及正位袋點 |
| KR20260005985A (ko) | 2023-05-05 | 2026-01-12 | 일라이 릴리 앤드 캄파니 | Er+ 유방암을 갖는 대상체에서 중추 신경계 (cns) 전이를 치료 및 예방하는 데 사용하기 위한 임루네스트란트 또는 그의 염 |
| WO2025036439A1 (en) * | 2023-08-16 | 2025-02-20 | Laekna Pharmaceutical Ningbo Co., Ltd. | Multicyclic compounds and their use as pi3k alpha inhibitors |
| WO2025144931A1 (en) * | 2023-12-27 | 2025-07-03 | Genesis Therapeutics, Inc. | Methods for treating cancer |
| WO2025201503A1 (en) * | 2024-03-28 | 2025-10-02 | InventisBio Co., Ltd. | Compounds, preparation methods and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515025D0 (en) * | 2005-07-21 | 2005-08-31 | Novartis Ag | Organic compounds |
| SI2170906T1 (sl) * | 2007-06-26 | 2013-07-31 | Ucb Pharma, S.A. | Zliti derivati tiazola, kot inhibitorji kinaze |
| JP2012521354A (ja) * | 2009-03-20 | 2012-09-13 | アムジエン・インコーポレーテツド | Ｐｉ３キナーゼの阻害薬 |
| DE102009043260A1 (de) * | 2009-09-28 | 2011-04-28 | Merck Patent Gmbh | Pyridinyl-imidazolonderivate |
| WO2011163195A1 (en) * | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
| HK1232227A1 (zh) * | 2014-07-04 | 2018-01-05 | Lupin Limited | 作为pi3k抑制剂的喹嗪酮衍生物 |
| AU2016287463B2 (en) * | 2015-07-02 | 2020-07-02 | F. Hoffmann-La Roche Ag | Benzoxazepin oxazolidinone compounds and methods of use |
| WO2017221272A1 (en) * | 2016-06-23 | 2017-12-28 | Sun Pharmaceutical Industries Limited | Process for the preparation of idelalisib |
| WO2021001431A1 (en) * | 2019-07-02 | 2021-01-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of pi3ka-selective inhibitors for treating metastatic disease in patients suffering from pancreatic cancer |
-
2022
- 2022-08-08 US US18/293,823 patent/US20240343728A1/en active Pending
- 2022-08-08 PE PE2024000156A patent/PE20240652A1/es unknown
- 2022-08-08 WO PCT/US2022/039674 patent/WO2023018636A1/en not_active Ceased
- 2022-08-08 KR KR1020247007455A patent/KR20240051953A/ko active Pending
- 2022-08-08 MA MA63885A patent/MA63885B1/fr unknown
- 2022-08-08 JP JP2024506896A patent/JP2024533975A/ja active Pending
- 2022-08-08 MX MX2024000708A patent/MX2024000708A/es unknown
- 2022-08-08 GE GEAP202416449A patent/GEAP202416449A/en unknown
- 2022-08-08 AU AU2022325819A patent/AU2022325819A1/en active Pending
- 2022-08-08 CN CN202280062281.6A patent/CN118159534A/zh active Pending
- 2022-08-08 IL IL310588A patent/IL310588A/en unknown
- 2022-08-08 EP EP22764505.8A patent/EP4363414A1/en active Pending
- 2022-08-08 CR CR20240045A patent/CR20240045A/es unknown
- 2022-08-08 CA CA3227902A patent/CA3227902A1/en active Pending
-
2024
- 2024-01-18 CO CONC2024/0000448A patent/CO2024000448A2/es unknown
- 2024-02-01 EC ECSENADI20248488A patent/ECSP24008488A/es unknown
- 2024-02-01 JO JOJO/P/2024/0020A patent/JOP20240020A1/ar unknown
- 2024-02-02 CL CL2024000327A patent/CL2024000327A1/es unknown
- 2024-02-02 ZA ZA2024/01094A patent/ZA202401094B/en unknown
- 2024-02-02 DO DO2024000019A patent/DOP2024000019A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024533975A5 (https=) | ||
| AU2005314155C1 (en) | Method for preparing N-phenylpyrazole-1-carboxamides | |
| JP2022534426A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| JP2009529540A5 (https=) | ||
| JP2017509586A5 (https=) | ||
| JP2015522650A5 (https=) | ||
| JP2010511721A5 (https=) | ||
| JP2005534684A5 (https=) | ||
| JP2018533593A5 (https=) | ||
| JP2012511564A5 (https=) | ||
| HRP20170104T1 (hr) | Derivati tipa azaindazola ili diazaindazola za liječenje boli | |
| JP2021522280A5 (https=) | ||
| JP2014503574A5 (https=) | ||
| JP2016121196A5 (https=) | ||
| JP2017504576A5 (https=) | ||
| JP2016517417A5 (https=) | ||
| RU2009105826A (ru) | 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ | |
| JP2005523922A5 (https=) | ||
| JP2017523169A5 (https=) | ||
| JP2024521895A5 (https=) | ||
| JP2006517976A5 (https=) | ||
| JP2016529306A5 (https=) | ||
| JP2011509302A5 (https=) | ||
| JP2018507223A5 (https=) |